Annual report

Period2023-03-01 → 2024-02-29
Filed2024-05-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
MetricValuePeriodScopeSource row
Revenue¥49.8bn2023-03-01 → 2024-02-29Cons.Net sales
Revenue¥44.1bn2022-03-01 → 2023-02-28Cons.Net sales
Revenue¥41.8bn2021-03-01 → 2022-02-28dCons.Net sales (5-year summary)
Revenue¥37.3bn2020-03-01 → 2021-02-28dCons.Net sales (5-year summary)
Revenue¥32.9bn2019-03-01 → 2020-02-29dCons.Net sales (5-year summary)
Operating income¥4.1bn2023-03-01 → 2024-02-29Cons.Operating income
Operating income¥4.0bn2022-03-01 → 2023-02-28Cons.Operating income
Ordinary income¥4.1bn2023-03-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥4.0bn2022-03-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥3.4bn2021-03-01 → 2022-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥2.5bn2020-03-01 → 2021-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥2.1bn2019-03-01 → 2020-02-29dCons.Ordinary income loss (5-year summary)
Profit before tax¥4.1bn2023-03-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥4.1bn2022-03-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥2.7bn2023-03-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.9bn2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2021-03-01 → 2022-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.6bn2020-03-01 → 2021-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.4bn2019-03-01 → 2020-02-29dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥2.6bn2023-03-01 → 2024-02-29Cons.Profit loss
Net income¥2.9bn2022-03-01 → 2023-02-28Cons.Profit loss
Total assets¥25.4bnat 2024-02-29Cons.Assets
Total assets¥22.8bnat 2023-02-28Cons.Assets
Total assets¥19.9bnat 2022-02-28dCons.Total assets (5-year summary)
Total assets¥18.1bnat 2021-02-28dCons.Total assets (5-year summary)
Total assets¥16.2bnat 2020-02-29dCons.Total assets (5-year summary)
Total liabilities¥9.7bnat 2024-02-29Cons.Liabilities
Total liabilities¥8.5bnat 2023-02-28Cons.Liabilities
Net assets / equity¥15.7bnat 2024-02-29Cons.Net assets
Net assets / equity¥14.2bnat 2023-02-28Cons.Net assets
Net assets / equity¥12.2bnat 2022-02-28dCons.Net assets
Net assets / equity¥10.3bnat 2021-02-28dCons.Net assets (5-year summary)
Net assets / equity¥8.4bnat 2020-02-29dCons.Net assets (5-year summary)
Cash and deposits¥11.5bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥9.3bnat 2023-02-28Cons.Cash and deposits
Cash & equivalents¥8.2bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥9.0bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥8.3bnat 2022-02-28dCons.Cash and cash equivalents
Cash & equivalents¥7.5bnat 2021-02-28dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥5.9bnat 2020-02-29dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥3.3bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥2.3bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥2.5bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.0bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.4bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.5bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥951m2022-03-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.2bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥431m2020-03-01 → 2021-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥816m2019-03-01 → 2020-02-29dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥600m2023-03-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow−¥605m2022-03-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow−¥706m2021-03-01 → 2022-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥63m2020-03-01 → 2021-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥442m2019-03-01 → 2020-02-29dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥120.842023-03-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥130.522022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.772021-03-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥74.252020-03-01 → 2021-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥63.62019-03-01 → 2020-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥119.532023-03-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥129.052022-03-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥99.22021-03-01 → 2022-02-28dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥74.22020-03-01 → 2021-02-28dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥62.272019-03-01 → 2020-02-29dCons.Diluted earnings per share (5-year summary)
Net assets per share¥713.59at 2024-02-29Cons.Net assets per share (5-year summary)
Net assets per share¥637.32at 2023-02-28Cons.Net assets per share (5-year summary)
Net assets per share¥540.83at 2022-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥455.87at 2021-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥386.09at 2020-02-29dCons.Net assets per share (5-year summary)
Equity ratio61.2%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio61.7%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio60.5%at 2022-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio56.2%at 2021-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2020-02-29dCons.Equity to asset ratio (5-year summary)
ROE18.0%2023-03-01 → 2024-02-29Cons.Rate of return on equity (5-year summary)
ROE22.2%2022-03-01 → 2023-02-28Cons.Rate of return on equity (5-year summary)
ROE20.0%2021-03-01 → 2022-02-28dCons.Rate of return on equity (5-year summary)
ROE17.9%2020-03-01 → 2021-02-28dCons.Rate of return on equity (5-year summary)
ROE17.7%2019-03-01 → 2020-02-29dCons.Rate of return on equity (5-year summary)
Employees2,326at 2024-02-29Cons.Number of employees
Employees2,176at 2023-02-28Cons.Number of employees
Employees1,840at 2022-02-28dCons.Number of employees
Employees1,771at 2021-02-28dCons.Number of employees
Employees1,692at 2020-02-29dCons.Number of employees
Revenue¥30.5bn2023-03-01 → 2024-02-29StandaloneNet sales
Revenue¥28.5bn2022-03-01 → 2023-02-28StandaloneNet sales
Revenue¥28.0bn2021-03-01 → 2022-02-28dStandaloneNet sales (5-year summary)
Revenue¥24.8bn2020-03-01 → 2021-02-28dStandaloneNet sales (5-year summary)
Revenue¥23.9bn2019-03-01 → 2020-02-29dStandaloneNet sales (5-year summary)
Operating income¥2.5bn2023-03-01 → 2024-02-29StandaloneOperating income
Operating income¥2.5bn2022-03-01 → 2023-02-28StandaloneOperating income
Ordinary income¥2.7bn2023-03-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥2.7bn2022-03-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥2.4bn2021-03-01 → 2022-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.8bn2020-03-01 → 2021-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.4bn2019-03-01 → 2020-02-29dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥2.6bn2023-03-01 → 2024-02-29StandaloneIncome before income taxes
Profit before tax¥2.7bn2022-03-01 → 2023-02-28StandaloneIncome before income taxes
Net income¥1.8bn2023-03-01 → 2024-02-29StandaloneProfit loss
Net income¥2.0bn2022-03-01 → 2023-02-28StandaloneProfit loss
Net income¥1.6bn2021-03-01 → 2022-02-28dStandaloneNet income loss (5-year summary)
Net income¥1.1bn2020-03-01 → 2021-02-28dStandaloneNet income loss (5-year summary)
Net income¥716m2019-03-01 → 2020-02-29dStandaloneNet income loss (5-year summary)
Total assets¥17.7bnat 2024-02-29StandaloneAssets
Total assets¥16.0bnat 2023-02-28StandaloneAssets
Total assets¥15.1bnat 2022-02-28dStandaloneTotal assets (5-year summary)
Total assets¥14.0bnat 2021-02-28dStandaloneTotal assets (5-year summary)
Total assets¥13.0bnat 2020-02-29dStandaloneTotal assets (5-year summary)
Total liabilities¥7.3bnat 2024-02-29StandaloneLiabilities
Total liabilities¥6.4bnat 2023-02-28StandaloneLiabilities
Net assets / equity¥10.4bnat 2024-02-29StandaloneNet assets
Net assets / equity¥9.6bnat 2023-02-28StandaloneNet assets
Net assets / equity¥8.5bnat 2022-02-28dStandaloneNet assets
Net assets / equity¥7.3bnat 2021-02-28dStandaloneNet assets (5-year summary)
Net assets / equity¥5.9bnat 2020-02-29dStandaloneNet assets (5-year summary)
Cash and deposits¥3.8bnat 2024-02-29StandaloneCash and deposits
Cash and deposits¥2.9bnat 2023-02-28StandaloneCash and deposits
EPS (basic)¥83.112023-03-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥90.962022-03-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥72.412021-03-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥50.652020-03-01 → 2021-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥33.512019-03-01 → 2020-02-29dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥82.212023-03-01 → 2024-02-29StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥89.932022-03-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥722021-03-01 → 2022-02-28dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.622020-03-01 → 2021-02-28dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥32.82019-03-01 → 2020-02-29dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥412023-03-01 → 2024-02-29StandaloneDividend paid per share (5-year summary)
Dividend per share¥272022-03-01 → 2023-02-28StandaloneDividend paid per share (5-year summary)
Dividend per share¥202021-03-01 → 2022-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥162020-03-01 → 2021-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥152019-03-01 → 2020-02-29dStandaloneDividend paid per share (5-year summary)
Net assets per share¥475.19at 2024-02-29StandaloneNet assets per share (5-year summary)
Net assets per share¥435.44at 2023-02-28StandaloneNet assets per share (5-year summary)
Net assets per share¥382.93at 2022-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥327.98at 2021-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥277.08at 2020-02-29dStandaloneNet assets per share (5-year summary)
Equity ratio58.5%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio59.9%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio56.7%at 2022-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio52.0%at 2021-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio45.6%at 2020-02-29dStandaloneEquity to asset ratio (5-year summary)
ROE18.3%2023-03-01 → 2024-02-29StandaloneRate of return on equity (5-year summary)
ROE22.3%2022-03-01 → 2023-02-28StandaloneRate of return on equity (5-year summary)
ROE20.4%2021-03-01 → 2022-02-28dStandaloneRate of return on equity (5-year summary)
ROE17.0%2020-03-01 → 2021-02-28dStandaloneRate of return on equity (5-year summary)
ROE12.6%2019-03-01 → 2020-02-29dStandaloneRate of return on equity (5-year summary)
Shares issued23,009,000at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued23,009,000at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued23,009,000at 2022-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued23,009,000at 2021-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued22,609,000at 2020-02-29dStandaloneTotal number of issued shares (5-year summary)
Employees1,120at 2024-02-29StandaloneNumber of employees
Employees1,034at 2023-02-28StandaloneNumber of employees
Employees961at 2022-02-28dStandaloneNumber of employees
Employees926at 2021-02-28dStandaloneNumber of employees
Employees872at 2020-02-29dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 97
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2023-03-01 → 2024-02-29¥12m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-03-01 → 2024-02-29¥3.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-03-01 → 2024-02-29¥3.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-03-01 → 2024-02-29¥286m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2024-02-29¥2.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-03-01 → 2024-02-29−¥200m
Reconciling Itemsreconcilingdepreciation2023-03-01 → 2024-02-29−¥7m
Reconciling Itemsreconcilingrevenue2023-03-01 → 2024-02-29−¥381m
Reconciling Itemsreconcilingrevenue intersegment2023-03-01 → 2024-02-29−¥381m
Reconciling Itemsreconcilingsegment assetsat 2024-02-29−¥3.0bn
Reconciling Itemsreconcilingsegment profit2023-03-01 → 2024-02-29¥2m
Accounting And Legal Fieldreportable segmentdepreciation2023-03-01 → 2024-02-29¥14m
Accounting And Legal Fieldreportable segmentemployeesat 2024-02-29121 pure
Accounting And Legal Fieldreportable segmentrevenue2023-03-01 → 2024-02-29¥2.5bn
Accounting And Legal Fieldreportable segmentrevenue external2023-03-01 → 2024-02-29¥2.5bn
Accounting And Legal Fieldreportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥10m
Accounting And Legal Fieldreportable segmentsegment assetsat 2024-02-29¥1.5bn
Accounting And Legal Fieldreportable segmentsegment profit2023-03-01 → 2024-02-29¥171m
Creative Field Japanreportable segmentdepreciation2023-03-01 → 2024-02-29¥249m
Creative Field Japanreportable segmentemployeesat 2024-02-291462 pure
Creative Field Japanreportable segmentrevenue2023-03-01 → 2024-02-29¥35.1bn
Creative Field Japanreportable segmentrevenue external2023-03-01 → 2024-02-29¥35.0bn
Creative Field Japanreportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥84m
Creative Field Japanreportable segmentsegment assetsat 2024-02-29¥18.3bn
Creative Field Japanreportable segmentsegment profit2023-03-01 → 2024-02-29¥2.9bn
Creative Field Koreareportable segmentdepreciation2023-03-01 → 2024-02-29¥8m
Creative Field Koreareportable segmentemployeesat 2024-02-2928 pure
Creative Field Koreareportable segmentrevenue2023-03-01 → 2024-02-29¥3.6bn
Creative Field Koreareportable segmentrevenue external2023-03-01 → 2024-02-29¥3.6bn
Creative Field Koreareportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥700,000
Creative Field Koreareportable segmentsegment assetsat 2024-02-29¥821m
Creative Field Koreareportable segmentsegment profit2023-03-01 → 2024-02-29−¥41m
Medical Fieldreportable segmentdepreciation2023-03-01 → 2024-02-29¥79m
Medical Fieldreportable segmentemployeesat 2024-02-29350 pure
Medical Fieldreportable segmentrevenue2023-03-01 → 2024-02-29¥5.4bn
Medical Fieldreportable segmentrevenue external2023-03-01 → 2024-02-29¥5.4bn
Medical Fieldreportable segmentsegment assetsat 2024-02-29¥5.7bn
Medical Fieldreportable segmentsegment profit2023-03-01 → 2024-02-29¥1.3bn
—segment totaldepreciation2023-03-01 → 2024-02-29¥350m
—segment totalrevenue2023-03-01 → 2024-02-29¥46.5bn
—segment totalrevenue external2023-03-01 → 2024-02-29¥46.4bn
—segment totalrevenue intersegment2023-03-01 → 2024-02-29¥95m
—segment totalsegment assetsat 2024-02-29¥26.3bn
—segment totalsegment profit2023-03-01 → 2024-02-29¥4.3bn
Total Of Reportable Segments And Otherssegment totaldepreciation2023-03-01 → 2024-02-29¥362m
Total Of Reportable Segments And Otherssegment totalrevenue2023-03-01 → 2024-02-29¥50.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-03-01 → 2024-02-29¥49.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-03-01 → 2024-02-29¥381m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-02-29¥28.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-03-01 → 2024-02-29¥4.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2022-03-01 → 2023-02-28¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-03-01 → 2023-02-28¥3.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-03-01 → 2023-02-28¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-03-01 → 2023-02-28¥302m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2023-02-28¥1.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-03-01 → 2023-02-28−¥275m
Reconciling Itemsreconcilingdepreciation2022-03-01 → 2023-02-28−¥3m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2023-02-28−¥381m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2023-02-28−¥381m
Reconciling Itemsreconcilingsegment assetsat 2023-02-28−¥2.6bn
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2023-02-28¥207,000
Accounting And Legal Fieldreportable segmentdepreciation2022-03-01 → 2023-02-28¥12m
Accounting And Legal Fieldreportable segmentrevenue2022-03-01 → 2023-02-28¥2.3bn
Accounting And Legal Fieldreportable segmentrevenue external2022-03-01 → 2023-02-28¥2.3bn
Accounting And Legal Fieldreportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥8m
Accounting And Legal Fieldreportable segmentsegment assetsat 2023-02-28¥1.4bn
Accounting And Legal Fieldreportable segmentsegment profit2022-03-01 → 2023-02-28¥160m
Creative Field Japanreportable segmentdepreciation2022-03-01 → 2023-02-28¥206m
Creative Field Japanreportable segmentrevenue2022-03-01 → 2023-02-28¥30.4bn
Creative Field Japanreportable segmentrevenue external2022-03-01 → 2023-02-28¥30.4bn
Creative Field Japanreportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥70m
Creative Field Japanreportable segmentsegment assetsat 2023-02-28¥16.5bn
Creative Field Japanreportable segmentsegment profit2022-03-01 → 2023-02-28¥2.7bn
Creative Field Koreareportable segmentdepreciation2022-03-01 → 2023-02-28¥7m
Creative Field Koreareportable segmentrevenue2022-03-01 → 2023-02-28¥3.5bn
Creative Field Koreareportable segmentrevenue external2022-03-01 → 2023-02-28¥3.5bn
Creative Field Koreareportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥1m
Creative Field Koreareportable segmentsegment assetsat 2023-02-28¥934m
Creative Field Koreareportable segmentsegment profit2022-03-01 → 2023-02-28−¥17m
Medical Fieldreportable segmentdepreciation2022-03-01 → 2023-02-28¥79m
Medical Fieldreportable segmentrevenue2022-03-01 → 2023-02-28¥5.2bn
Medical Fieldreportable segmentrevenue external2022-03-01 → 2023-02-28¥5.2bn
Medical Fieldreportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥1m
Medical Fieldreportable segmentsegment assetsat 2023-02-28¥5.1bn
Medical Fieldreportable segmentsegment profit2022-03-01 → 2023-02-28¥1.3bn
—segment totaldepreciation2022-03-01 → 2023-02-28¥304m
—segment totalrevenue2022-03-01 → 2023-02-28¥41.4bn
—segment totalrevenue external2022-03-01 → 2023-02-28¥41.4bn
—segment totalrevenue intersegment2022-03-01 → 2023-02-28¥80m
—segment totalsegment assetsat 2023-02-28¥23.9bn
—segment totalsegment profit2022-03-01 → 2023-02-28¥4.2bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-03-01 → 2023-02-28¥308m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2023-02-28¥44.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2023-02-28¥44.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2023-02-28¥381m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-02-28¥25.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2023-02-28¥4.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,681
ItemContextValueUnit
Interest expenses noeCurrentYearDuration6194000JPY
Foreign exchange losses noePrior1YearDuration488000JPY
Foreign exchange losses noeCurrentYearDuration-JPY
Provision of allowance for doubtful accounts noePrior1YearDuration-JPY
Provision of allowance for doubtful accounts noeCurrentYearDuration13122000JPY
Equity in losses of affiliates noePrior1YearDuration-JPY
Equity in losses of affiliates noeCurrentYearDuration5289000JPY
Miscellaneous loss noePrior1YearDuration10303000JPY
Miscellaneous loss noeCurrentYearDuration5170000JPY
Other noePrior1YearDuration3322000JPY
Other noeCurrentYearDuration1671000JPY
Non operating expensesPrior1YearDuration18513000JPY
Non operating expensesCurrentYearDuration31448000JPY
Ordinary incomePrior1YearDuration4002032000JPY
Ordinary incomeCurrentYearDuration4137200000JPY
Gain on sales of noncurrent assets eiPrior1YearDuration-JPY
Gain on sales of noncurrent assets eiCurrentYearDuration363000JPY
Gain on sales of investment securities eiPrior1YearDuration30000000JPY
Gain on sales of investment securities eiCurrentYearDuration-JPY
Gain on sales of subsidiaries stocks eiPrior1YearDuration36377000JPY
Gain on sales of subsidiaries stocks eiCurrentYearDuration-JPY
Gain on step acquisitions eiPrior1YearDuration95900000JPY
Gain on step acquisitions eiCurrentYearDuration-JPY
Extraordinary incomePrior1YearDuration162277000JPY
Extraordinary incomeCurrentYearDuration363000JPY
Loss on retirement of noncurrent assets elPrior1YearDuration3553000JPY
Loss on retirement of noncurrent assets elCurrentYearDuration2770000JPY
Loss on sales of noncurrent assets elPrior1YearDuration-JPY
Loss on sales of noncurrent assets elCurrentYearDuration105000JPY
Loss on sales of investment securities elPrior1YearDuration-JPY
Loss on sales of investment securities elCurrentYearDuration17450000JPY
Office transfer expense elPrior1YearDuration1591000JPY
Office transfer expense elCurrentYearDuration-JPY
Settlement package elPrior1YearDuration57497000JPY
Settlement package elCurrentYearDuration-JPY
Loss due to new corona virus infection elPrior1YearDuration1362000JPY
Loss due to new corona virus infection elCurrentYearDuration-JPY
Impairment loss elPrior1YearDuration-JPY
Impairment loss elCurrentYearDuration39924000JPY
Loss on liquidation of subsidiaries general elPrior1YearDuration-JPY
Loss on liquidation of subsidiaries general elCurrentYearDuration258000JPY
Extraordinary lossPrior1YearDuration64005000JPY
Extraordinary lossCurrentYearDuration60508000JPY
Income before income taxesPrior1YearDuration4100305000JPY
Income before income taxesCurrentYearDuration4077055000JPY
Income taxes currentPrior1YearDuration1194225000JPY
Income taxes currentCurrentYearDuration1428502000JPY
Income taxes deferredPrior1YearDuration12802000JPY
Income taxes deferredCurrentYearDuration793000JPY
Income taxesPrior1YearDuration1207027000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-02-28pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
balance sheet identitynon_consolidated 2023-02-28pass
balance sheet identitynon_consolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net assetsnon_consolidated 2022-02-28pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-03-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-03-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-03-01/2024-02-29pass
statement vs summary · revenuenon_consolidated 2022-03-01/2023-02-28pass
statement vs summary · revenuenon_consolidated 2023-03-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsconsolidated 2024-02-29pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass